Avoro Capital Advisors LLC Ptc Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $14.7 Million - $18.5 Million	-324,750 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $37.3 Million - $48.1 Million	-875,250 Reduced 72.94%	324,750 $16.5 Million
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $38.8 Million - $71.2 Million	1,200,000 New	1,200,000 $53.5 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $22 Million - $34.2 Million	-684,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $24.2 Million - $30.8 Million	684,000 New	684,000 $30.8 Million
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $10.7 Million - $15 Million	-380,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $9.07 Million - $14.1 Million	-304,000 Reduced 44.44%	380,000 $13 Million
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $54.6 Million - $77 Million	-1,610,877 Reduced 70.19%	684,000 $32.1 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $59 Million - $110 Million	2,294,877 New	2,294,877 $77.4 Million

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.